HolmesAI to Bring its CLholmes® platform into Southeast Asia: Diagnosing and Predicting Heart Disease with AI Technology
HolmesAI, with the CLholmes® platform that diagnoses 21 types of cardiac arrhythmias, plans to participate in CES 2025. SEOUL, SOUTH KOREA, September 23, 2024 /EINPresswire.com/ -- HolmesAI (CEO Dong Seok Lim) participated in the ‘Global Media …